News in the Life Sciences Industry

STOCKHOLM, May 21, 2019 /PRNewswire/ -- Essity is divesting its 50% stake in the partly owned company SCA Yildiz in Turkey to the other part owner Yildiz.

STOCKHOLM, May 21, 2019 /PRNewswire/ -- "The initiation of the filing process for melflufen in the US is a major milestone for Oncopeptides."

STOCKHOLM, May 21, 2019 /PRNewswire/ -- Important events January-March 2019

STOCKHOLM, May 20, 2019 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company will receive a milestone payment of MEUR 15 from its partner Eisai for the achievement of the first patient being dosed in the global, single confirmatory Phase 3 study (Clarity... Read more ››

STOCKHOLM, May 20, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that, after discussions with the FDA, the company has initiated the preparation for submitting a New Drug Application (NDA) for accelerated approval of melflufen for the treatment of patients... Read more ››

UPPSALA, Sweden, May 17, 2019 /PRNewswire/ -- Orexo AB (publ.), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces that the company will be presenting at the following events taking place in May and June.

STOCKHOLM, May 17, 2019 /PRNewswire/ -- Proton Therapy Center Czech (Prague PTC) is the only one of its kind in Czechia, and it has selected RayStation® as its sole treatment planning system. This is RaySearch's first order from Czechia.